三元基因
(920344)
| 流通市值：22.88亿 | | | 总市值：24.51亿 |
| 流通股本：1.14亿 | | | 总股本：1.22亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 60,093,322.03 | 285,997,870.92 | 162,911,319.82 | 118,359,681.58 |
| 营业收入 | 60,093,322.03 | 285,997,870.92 | 162,911,319.82 | 118,359,681.58 |
| 二、营业总成本 | 57,763,087.32 | 282,481,085.76 | 182,546,297.79 | 125,349,885.16 |
| 营业成本 | 11,177,983.05 | 62,414,742.08 | 38,358,890.06 | 26,982,323.77 |
| 税金及附加 | 1,368,427.17 | 6,560,129.18 | 4,718,060.91 | 3,190,106.76 |
| 销售费用 | 25,764,236.52 | 133,932,123.17 | 79,066,875.93 | 53,807,131.94 |
| 管理费用 | 9,913,399.03 | 44,132,189.23 | 33,191,255.44 | 23,284,253.38 |
| 研发费用 | 5,930,593.77 | 24,666,658.55 | 19,468,424.75 | 12,935,755.86 |
| 财务费用 | 3,608,447.78 | 10,775,243.55 | 7,742,790.7 | 5,150,313.45 |
| 其中:利息费用 | 3,701,322.35 | 11,329,226.88 | 8,221,972.04 | 5,568,498.93 |
| 其中:利息收入 | 99,894.49 | 581,295.97 | 499,374.98 | 432,445.03 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -1,040,613.33 | -750,000 | -500,000 | -345,597.41 |
| 资产处置收益 | -882.91 | -27,444.69 | -27,491.3 | -16,282.81 |
| 资产减值损失(新) | -349,739.51 | -190,356.82 | -88.17 | -88.17 |
| 信用减值损失(新) | 184,913.74 | -898,626.6 | -318,682.36 | -769,088.16 |
| 其他收益 | 575,457.42 | 2,413,359.16 | 1,851,903.5 | 1,298,761.92 |
| 四、营业利润 | 1,699,370.12 | 4,063,716.21 | -18,629,336.3 | -6,822,498.21 |
| 加:营业外收入 | - | 34,660.62 | 34,048.39 | 48.39 |
| 减:营业外支出 | 210,442.7 | 381,788.56 | 378,363.66 | 299,319.06 |
| 五、利润总额 | 1,488,927.42 | 3,716,588.27 | -18,973,651.57 | -7,121,768.88 |
| 减:所得税费用 | 420,284.1 | -1,420,876.3 | -4,694,484.56 | -656,328.01 |
| 六、净利润 | 1,068,643.32 | 5,137,464.57 | -14,279,167.01 | -6,465,440.87 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,068,643.32 | 5,137,464.57 | -14,279,167.01 | -6,465,440.87 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 1,068,643.32 | 5,137,464.57 | -14,279,167.01 | -6,465,440.87 |
| 扣除非经常损益后的净利润 | 735,660.47 | 3,417,955.06 | -15,479,925.89 | -7,255,200.51 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.04 | -0.12 | -0.05 |
| (二)稀释每股收益 | 0.01 | 0.04 | -0.12 | -0.05 |
| 九、综合收益总额 | 1,068,643.32 | 5,137,464.57 | -14,279,167.01 | -6,465,440.87 |
| 归属于母公司股东的综合收益总额 | 1,068,643.32 | 5,137,464.57 | -14,279,167.01 | -6,465,440.87 |
| 公告日期 | 2026-04-28 | 2026-04-10 | 2025-10-29 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |